Hyphens Pharma International Limited reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was SGD 42.82 million compared to SGD 42.76 million a year ago. Net income was SGD 2.14 million compared to SGD 4.05 million a year ago.
For the nine months, sales was SGD 117.53 million compared to SGD 123.46 million a year ago. Net income was SGD 5.66 million compared to SGD 10.29 million a year ago.